Tail-anchored (TA) membrane proteins destined for the endoplasmic reticulum are chaperoned by cytosolic targeting factors that deliver them to a membrane receptor for insertion. Although a basic framework for TA protein recognition is now emerging, the decisive targeting and membrane insertion steps are not understood. Here we reconstitute the TA protein insertion cycle with purified components, present crystal structures of key complexes between these components and perform mutational analyses based on the structures. We show that a committed targeting complex, formed by a TA protein bound to the chaperone ATPase Get3, is initially recruited to the membrane through an interaction with Get2. Once the targeting complex has been recruited, Get1 interacts with Get3 to drive TA protein release in an ATPase-dependent reaction. After releasing its TA protein cargo, the now-vacant Get3 recycles back to the cytosol concomitant with ATP binding. This work provides a detailed structural and mechanistic framework for the minimal TA protein insertion cycle.
Tail-anchored (TA) membrane proteins destined for the endoplasmic reticulum are chaperoned by cytosolic targeting factors that deliver them to a membrane receptor for insertion. Although a basic framework for TA protein recognition is now emerging, the decisive targeting and membrane insertion steps are not understood. Here we reconstitute the TA protein insertion cycle with purified components, present crystal structures of key complexes between these components and perform mutational analyses based on the structures. We show that a committed targeting complex, formed by a TA protein bound to the chaperone ATPase Get3, is initially recruited to the membrane through an interaction with Get2. Once the targeting complex has been recruited, Get1 interacts with Get3 to drive TA protein release in an ATPase-dependent reaction. After releasing its TA protein cargo, the now-vacant Get3 recycles back to the cytosol concomitant with ATP binding. This work provides a detailed structural and mechanistic framework for the minimal TA protein insertion cycle.
Approximately 5% of eukaryotic membrane proteins are anchored to the lipid bilayer by a single carboxy-terminal transmembrane domain [1] [2] [3] [4] (TMD). These 'tail-anchored' proteins are found in virtually all cellular membranes and perform essential functions in processes including protein trafficking, degradation, cell death and membrane biogenesis. TA proteins in compartments of the secretory and endocytic pathways are first targeted to and inserted into the ER membrane by a posttranslational targeting pathway conserved across eukaryotes [5] [6] [7] [8] [9] and archaea 10, 11 . This pathway begins with a 'pre-targeting' factor that captures newly synthesized TA proteins through their TMDs near the ribosome 12, 13 . In yeast, the pre-targeting factor is Sgt2, which assembles with Get3, Get4 and Get5 (also known as Mdy2) to form a TMD recognition complex 12, 14, 15 . Assembly of TMD recognition complexes permits substrates to be transferred from Sgt2 to Get3 in an ATP-dependent manner 12 . Get3 (TRC40, or ASNA1, in mammals) is a homodimeric ATPase whose conformation is regulated by its nucleotide state [16] [17] [18] [19] [20] . Both crystallographic and functional analyses support a model in which an ATP-bound, 'closed' dimer of Get3 binds substrates in a large hydrophobic groove that spans both subunits [16] [17] [18] 20 . This substrateGet3-nucleotide complex is therefore the committed targeting complex (Supplementary Discussion).
In yeast, genetic and physical interaction studies have identified the ER-localized membrane proteins Get1 and Get2 as potential receptors for Get3 (refs 7, 21) . It is not known whether Get1, Get2 and Get3 constitute the minimal targeting and insertion machinery, how they function or what their essential roles are during TA protein insertion. In this Article, we combine functional reconstitution of TA protein insertion with structural analysis of key intermediate complexes to provide a mechanistic framework for the TA protein insertion cycle in Saccharomyces cerevisiae.
The minimal insertion machinery
We first reconstituted the TA protein insertion cycle with purified recombinant factors. A functional TA protein targeting complex was assembled and purified from in vitro translation reactions (Supplementary Fig. 1 ). The complex contained radio-labelled and epitope-tagged Sec61b (an ER-localized TA protein) bound to recombinant yeast Get3 in roughly the 2:1 ratio expected from structural studies. This recombinant targeting complex was functional as judged by membrane insertion of Sec61b into ER-derived yeast rough microsomes (yRMs) but not into protein-free liposomes (Fig. 1a) . Microsomes from DGet1 and DGet2 yeast strains showed little insertion activity, whereas DGet3 microsomes were similar to wildtype yRMs. Sec61b insertion efficiency with the purified targeting complex was approximately two-fold higher than for Sec61b in crude translation reactions (data not shown), consistent with the observation that the latter contains a heterogeneous mixture of Sec61b complexes with other factors 8, 13, 22 . Thus, purified Get3-Sec61b is a committed targeting complex for Get1-and Get2-dependent membrane insertion.
The TA insertion defect of DGet1 and DGet2 microsomes is due solely to loss of Get1 and/or Get2. To show this, purified recombinant Get1 and Get2 (rGet1 and rGet2; Supplementary Fig. 2 ) produced from Escherichia coli were added to detergent extracts prepared from DGet1 or DGet2 yRMs, reconstituted into proteoliposomes and tested for function ( Supplementary Fig. 3 ). Proteoliposomes from DGet1 yRMs were inactive for TA protein insertion, but were restored by replenishment with physiologic levels of rGet1 but not rGet2. DGet2 proteoliposomes required both rGet1 and rGet2 to restore insertion to near wild-type levels ( Supplementary Fig. 3 ), as expected because Get1 is absent from DGet2 yRMs (Fig. 1a) . We also biochemically depleted Get1 and Get2 from wild-type yRM and showed that the resulting insertion defect could be corrected by replenishment with rGet1 and rGet2 but with neither individually ( Supplementary Fig. 4 ). Thus, rGet1 and rGet2 are fully functional in replacing their native counterparts during Get3-dependent TA protein insertion.
The lack of membrane proteins co-purifying with Get1 and Get2 ( Supplementary Fig. 5 ), and the absence of other membrane proteins found in genetic studies 15, 23, 24 , suggested that Get1 and Get2 are sufficient for Get3-mediated TA protein insertion. Indeed, proteoliposomes containing physiologic concentrations of only rGet1 and rGet2 (Fig. 1b, c) were indistinguishable from yRM in mediating insertion of three different purified TA protein targeting complexes (Fig. 1d) . Incorporating super-physiologic levels of rGet1 and rGet2 did not further improve insertion (Fig. 1d) , and lower levels reduced overall insertion efficiency (Fig. 1e) . The recombinant system required both rGet1 and rGet2 (Fig. 1e) , precisely mirroring the results in vivo 7 and in crude proteoliposomes ( Supplementary Figs 3 and 4) . Interaction analysis confirmed that rGet1 and rGet2 form a complex through their membrane domains in detergent solution ( Supplementary Fig. 6 ), suggesting that during reconstitution they are incorporated as a complex. Taken together, the dependence on rGet1 and rGet2, their interaction with each other, their functionality in replacing the endogenous proteins and the highefficiency insertion at native concentrations argue strongly that we have reconstituted physiologically relevant TA protein insertion with a defined targeting complex and only two membrane proteins.
The Get2c-Get3-ADPNAlF 4 2 complex
Membrane targeting presumably involves an interaction between Get3 and the conserved cytosolic domains of Get1 and/or Get2 (Figs 2a and 3a and Supplementary Fig. 10 ). These fragments ('Get1c' and 'Get2c') did not interact with each other (Supplementary Figs 6 and 7), but both bound tightly to Get3 (Supplementary Figs 7 and 8) and inhibited the insertion of Sec61b into yRMs ( Supplementary Fig. 8 ). The ability of Get3 to interact with either subunit of the Get1/2 complex suggested that each interaction might serve a different purpose in the insertion cycle.
The closed-dimer form of ADPNAlF 4
2
-bound Get3 probably mimics the TA substrate-bound conformation that targets to the membrane [16] [17] [18] 20 . This Get3-ADPNAlF 4 2 complex crystallized with Get2c, and we determined the structure to a resolution of 2.1 Å (Supplementary Table 1 and Supplementary Fig. 9 ). The structure reveals Get3 in a 'closed'-dimer conformation with ADPNAlF 4 2 bound at each active site (Fig. 2b) . Two Get2 fragments, each comprising two helices connected by a short linker, bind to equivalent sites on opposite faces of the symmetric Get3 homodimer. Each interface buries ,960 Å 2 of surface area, largely restricted to a single Get3 monomer (Fig. 2c , green, and RESEARCH ARTICLE Supplementary Fig. 10 ). Get3 residues within the interface undergo little conformational change on binding to Get2c ( Supplementary Fig. 11 ). The amino-terminal helix of Get2 lies in a cleft defined at one end by short loops following helices a10 and a11 of Get3, and at the other end by the loop following helix a9 and the extreme N terminus of Get3 (Fig. 2d ). Three conserved, negatively charged residues in Get3, namely Asp 265, Glu 307 and Asp 308, make direct contact with Get2c. The second helix of Get2 lies in a cleft defined by Get3 helices a10 and a11 (Fig. 2e ). This surface is largely hydrophobic except for a conserved salt bridge between Glu 253 (Get3) and Arg 29 (Get2c). The C-terminal end of the Get2 fragment, which is not conserved, makes poorly ordered contacts with the adjacent Get3 monomer (Fig. 2c, blue) .
The TA substrate-binding site in Get3 comprises a large hydrophobic groove spanning the a-helical subdomains of both monomers 16 . In the Get2c-Get3 complex, this groove is intact ( Fig. 2b and Supplementary  Fig. 20 ), suggesting that Get2 captures the closed Get3 targeting complex without disrupting the TA binding site. The long, flexible linker that tethers the helical N terminus of Get2 to its first TMD would facilitate this process. Thus, we propose that the Get2c-Get3-ADPNAlF 4 2 structure represents a snapshot of the initial encounter between the closed-dimer targeting complex and the receptor.
The Get1c-Get3 complex
Get3 was also crystallized in the presence of Get1c. Whether or not ADPNAlF 4 2 was present during crystallization, the Get3-Get1c crystals lacked nucleotide. We determined the structure of this nucleotidefree complex to a resolution of 3.0 Å (Supplementary Table 1 and Supplementary Fig. 9 ) and revealed Get3 in an 'open' conformation, with two Get1 fragments bound to equivalent sites on opposite faces of the symmetric Get3 homodimer (Fig. 3b) . Each Get1 fragment adopts an antiparallel coiled-coil structure and buries ,1,030 Å 2 of surface area in a bipartite interface split evenly between the two Get3 subunits ( Fig. 3c and Supplementary Fig. 10 ). As observed in the Get2c complex, Get3 residues on the interface undergo little conformational change on binding to Get1c ( Supplementary Fig. 11 ). Binding to one Get3 monomer is primarily mediated by hydrophobic contacts between helix a2 of Get1c and the cleft defined by helices a10 and a11 of Get3 (Fig. 3c, d , green). Binding to the other monomer is mediated by helix a1 of Get1c, which interacts with Get3 helices a4 and a5, and by a six-residue loop in Get1c that directly contacts the ATP-binding site (Fig. 3c , e, blue; see below).
Importantly, many of the Get3 residues that contact Get1c also mediate interactions with Get2c ( Supplementary Figs 10 and 11 ). For example, the conserved Arg 73 (Get1c)/Glu 253 (Get3) salt bridge almost perfectly mimics the Arg 29 (Get2c)/Glu 253 (Get3) interaction (Figs 2e and 3d) . The presence of overlapping binding sites suggests that Get1 and Get2 cannot simultaneously occupy the same site on Get3, as illustrated by dissociation of the Get3-Get2c complex by Get1c ( Supplementary Fig. 11 ). Previous work underscores the functional significance of this region of Get3: alanine substitutions within the shared interface, including F246A, Y250A, E253A and Y298A, have a strong loss-of-function phenotype in yeast 18 . Moreover, two of these positions, Tyr 250 and Glu 253, have been implicated in the ATP-dependent binding of Get4 25 . Thus, the a10-a11 region of Get3 is a binding hotspot that probably plays an important regulatory role at different stages of the targeting cycle.
The most striking aspect of the Get3-Get1c structure is how the Get1 coiled coil wedges between the Get3 subunits, completely disrupting the hydrophobic TA substrate-binding site (Fig. 3b) . Such an interaction could effect substrate release from the Get3 targeting complex. However, parts of the bipartite Get1-binding site on Get3-including the ATPase motifs and portions of helices a4 and a5 (Fig. 3c, blue) -are buried in the ATP-bound, fully closed-dimer conformation. By contrast, the bipartite Get1-binding site is largely exposed to solvent in the Mg 21 -ADP-bound state 17, 20 ( Supplementary  Fig. 12 ). This implies that ATP hydrolysis by the targeting complex is needed to expose the Get1-binding site on Get3 (Fig. 3c and Supplementary Fig. 12 , green and blue). Once exposed, Get1 would complete the Get3 transition from closed to open, disrupting the hydrophobic groove to promote release of the TA substrate and ADP (which binds weakly to substrate-free Get3; Supplementary  Fig. 18 ). Importantly, the rigid Get1 coiled coil is perpendicular to cerevisiae Get1 with a large cytosolic-facing region (magenta). b, Structure of two Get1 fragments (magenta) bound to the open dimer state of Get3 (green, blue). The composite hydrophobic groove is completely disrupted. c, Get3 residues in the Get1 interface are indicated; significant contacts are made to both monomers (green, blue), including the P-loop, switch I and switch II ATPase motifs. d, Close-up of interactions between Get1 helix a2 (magenta) and one Get3 monomer (green), including the conserved salt bridge between Arg 73 and Glu 253. This interface overlaps extensively with the Get2c binding surface ( Fig. 2e and Supplementary Fig. 11 ). e, Close-up of interactions between the Get1 hairpin loop and the active site of the adjacent Get3 monomer (blue).
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the plane of the membrane, thereby positioning the hydrophobic groove of Get3 parallel to the membrane. This implies that the TMD of a TA protein is precisely released along the membrane surface, presumably facilitating its subsequent insertion.
Targeting and substrate release
Conserved contacts between Get3-Get2 and Get3-Get1 were disrupted with point mutations (R17E and R73E, respectively), verified to prevent binding ( Supplementary Fig. 13 ) and shown to reduce insertion in the reconstituted system sharply (Fig. 4a) . When the substrate-Get3 interaction was monitored by crosslinking (Supplementary Fig. 14) , Get1c, but not Get2c, was found to release TA substrate from Get3 (.50% at 500 nM; Fig. 4b ). This activity was abolished by the R73E mutation that disrupts Get3-Get1c interactions (Fig. 4c) . Thus, Get1c and Get2c both inhibit insertion ( Supplementary Fig. 8 ), but for different reasons: Get1c causes premature substrate release whereas Get2c competitively precludes targeting. When reconstituted into proteoliposomes at more-physiologic concentrations, neither rGet1 nor rGet2 was able to effect substrate release, whereas the complete rGet1/2 complex was active (Fig. 4d) . Importantly, disrupting the Get3-Get1 interaction (with R73E) or the Get3-Get2 interaction (with R17E) abolished the ability of the rGet1/2 complex to stimulate substrate release (Fig. 4e) . Thus, whereas Get1c at super-physiologic concentrations can drive substrate release on its own, full-length Get1 in the membrane is unable to do so at physiologic levels. In this context, Get1 requires Get2 (specifically its ability to bind Get3) to release substrate from Get3.
On the basis of the Get3-Get1c structure, ATP hydrolysis by the Get3 targeting complex is likely to be necessary for its interaction with Get1. Indeed, targeting complexes containing an ATPase-deficient Get3 mutant (D57N) were poorly inserted into proteoliposomes containing the rGet1/2 complex (Fig. 4f) despite no impairment of the interaction of Get3 (D57N) with substrate or the rGet1/2 complex ( Supplementary Fig. 15 and data not shown) . Analysis of the interaction between TA substrate and Get3 (D57N) revealed that the rGet1/2 complex was unable to induce release (Fig. 4d, e) . Taken together, the results of the functional analysis indicate that the Get3-Get2 interaction is important for targeting, and that this step is a prerequisite for substrate release. Substrate release, in turn, depends on both ATP hydrolysis by Get3 and the ability of Get3 to interact with Get1.
ATP-dependent recycling
The ATP that Get3 hydrolyses before substrate release is apparently acquired from the in vitro translation reaction (and maintained during purification) because insertion proceeds efficiently without additional ATP in the purified system (Fig. 5a ). This is consistent with structural analysis suggesting that nucleotide is shielded from bulk solvent in the fully closed Get3-ATP-substrate ternary complex (Supplementary Discussion). However, we ( Supplementary Fig. 16 ) and others 6, 17 have found that insertion reactions into crude yRMs, but not rGet1/2 proteoliposomes, are stimulated by ATP, non-hydrolysable ATP analogues or ADP. The explanation for this discrepancy proved to be the near-stoichiometric presence of Get3 on the Get1/2 complex in yRMs ( Supplementary Fig. 5 ), but not on rGet1/2 proteoliposomes. Accordingly, binding Get3 to rGet1/2 proteoliposomes restored ATP dependence (Fig. 5b) , whereas removing Get3 from yRM (by using DGet3 yeast) eliminated the ATP requirement for maximal insertion (Fig. 5c) .
These results indicate that after TA substrate release, Get3 remains bound to microsomal membranes. In the nucleotide-free Get3-Get1c structure, which mimics this 'post-insertion' complex, residues within the conserved loop of Get1 ( 59 ISAQDN 64 ) insert into the Get3 active site (Fig. 3e) and deform it relative to the ADPNAlF 4 2 -bound conformation (Fig. 5d) . Modelling ATP into the active site reveals steric and electrostatic clashes between Get1 and ATP, suggesting that free ATP should displace Get3 from Get1. Indeed, the Get3-Get1c interaction was quantitatively disrupted by micromolar concentrations of ATP (Fig. 5e) . ADP was far less effective, and AMP failed to disrupt the Get3-Get1c complex. This ATP-dependent Get3 dissociation was also verified with full-length Get1 using pull-down assays (Supplementary Fig. 19 ). By contrast, none of the tested nucleotides a, Insertion assay with purified Get3-Sec61b targeting complex and proteoliposomes containing the indicated purified proteins. Liposomes and yRM are controls. Get1* and Get2* indicate mutants inactive in Get3 interaction (R73E and R17E, respectively). b, Substrate release from targeting complexes incubated with Get1c or Get2c; release was monitored by loss of the crosslink (XL) between radio-labelled substrate and Get3. Square brackets indicate concentration. c, As in b, with wild-type and mutant fragments at a concentration of 0.5 mM. d, Substrate interaction with Get3 or the ATPase-deficient Get3 (D57N) was assessed by crosslinking after incubation with liposomes or proteoliposomes containing the indicated recombinant proteins. e, As in d, but comparing wild-type and mutant complexes of Get1 and Get2. f, Relative efficiency of insertion (mean 6 s.e.m.; n 5 6) into rGet1/2 proteoliposomes with targeting complexes prepared from wild-type Get3 or Get3 (D57N). -bound Get3 dimer (grey). Steric (dashed lines) and electrostatic clashes between conserved residues in Get1 and the nucleotide c-phosphate are apparent. e, Dissociation of Get3-Get1c, monitored by the change in fluorescence resonance energy transfer (DF), on titration with the indicated nucleotides. Curve fits of triplicate measurements (mean 6 s.e.m.) are shown. a.u., arbitrary units. The reaction contained 10 nM Get3 (D57N) and 100 nM Get1c. f, As in e, but with 10 nM Get3 (D57N) and 200 nM Get2c.
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disrupted Get2c binding to Get3 (Fig. 5f) . Thus, free ATP binding dissociates the Get1-Get3 complex to recycle Get3 from the membrane after TA substrate release.
A model for the insertion cycle Figure 6 illustrates our working framework for the insertion cycle. Substrate-bound Get3 in the closed conformation and loaded with nucleotide (either ATP or ADP; see Supplementary Discussion) is captured at the membrane by the cytosolic domain of Get2. The apparently long and flexible Get2 tether may facilitate this initial encounter and bring the intact targeting complex near to the site of insertion. After this targeting step, Get1 mediates the post-targeting reactions of substrate release and insertion. Get1 binding to the targeting complex would be facilitated by partial destabilization of the closed dimer after ATP hydrolysis, and by the high local concentration of Get3 achieved by its recruitment through Get2. Binding to the rigid Get1 coiled coil would orient Get3 such that the substrate is in close proximity to the membrane. Moreover, by stabilizing the open conformation, Get1 binding would disrupt the Get3 hydrophobic groove and promote release of substrate and ADP. At present, we do not know whether the Get1/2 complex functions as a heterodimer or heterotetramer, although we favour the latter given the symmetric structure of the Get3 dimer. The released substrate would insert unassisted into the lipid bilayer directly 26, 27 or would be chaperoned by the TMDs of the Get1/2 complex. Finally, the empty Get3 would be released from Get1 concomitant with ATP binding, and would be primed to accept the next substrate from the cytosolic pre-targeting complex for another round of targeting.
METHODS SUMMARY
Reagents and assays. Constructs, proteins and antibodies derived from earlier studies 8, 13, 16 are described in Methods. Antibodies against Get1 and Get2 were produced in rabbits. In vitro translation, insertion, crosslinking and immunoprecipitation were as described previously 8, 13, 28 . Get1 and Get2 (full length and fragments) were expressed in E. coli and purified by Ni-NTA chromatography; fragments were further purified by size exclusion chromatography. 35 S-labelled targeting complexes were affinity-purified from in vitro translation reactions containing recombinant Get3. Liposomes, microsomes and proteoliposomes. Liposomes containing a 4:1 ratio of egg phosphatidylcholine and dipalmotylphosphatidylethanolamine were prepared by extrusion 27, 29 . Yeast rough microsomes were prepared as before [30] [31] [32] [33] . Proteoliposome reconstitutions from solubilized yRMs or purified Get1 and/or Get2 were done by optimizing ( Supplementary Fig. 17 ) earlier methods 30, 33, 34 . Interaction analysis. Binding assays were performed by gel filtration and multiangle light scattering, pull-down assays or fluorescence resonance energy transfer. Substrate release was monitored by amine-reactive crosslinking 8 . Structure determination. Complexes of Get3 with Get1c or Get2c were coexpressed in E. coli and purified by Ni-NTA and size exclusion chromatography. Diffraction data were collected at Advanced Photon Source beamline 21-IDG, Argonne National Laboratory. Structures were determined by molecular replacement in PHASER 35 . Refinement and model building was done using PHENIX 36 and COOT 37 .
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
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METHODS
Reagents and basic procedures. Antibodies against Get1 (residues 61-74) and Get2 (residues 2-12) were generated against synthetic peptides conjugated to KLH via terminal cysteines. Antibody against yeast Get3 was against the whole recombinant protein. Antibody production was by LAMPIRE Biological Laboratories. The antibodies against the 3F4 tag and Sec61b have been described previously 8 . The Sec61a antibody was a gift from Tom Rapoport (Harvard University). DeoxyBigCHAP (DBC) was obtained from Calbiochem. Yeast strains were from Open Biosystems collections and were provided by Tom Dever. The following lipids were obtained from Avanti Polar Lipids: egg phosphatidylcholine (PC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (PE) and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-lissamine rhodamine B (rhodamine-PE). Each lipid was dissolved and stored in chloroform at 220 uC or 280 uC. Protease inhibitor cocktail was from Roche (EDTA-free Complete tablets) and dissolved as a 325 stock in aqueous buffer just before use. In vitro translation, chemical crosslinking and immunoprecipitations were as described previously 8, 13, 28 . Preparation of proteins for functional analysis. The genes encoding full-length or cytosolic fragments of S. cerevisiae Get1, Get2 and Get3 were amplified by PCR from genomic DNA. Site-directed mutants were obtained by QuikChange mutagenesis (Stratagene). Unless otherwise noted, all constructs were subcloned into a pET28 derivative (Novagen) modified to incorporate a tobacco etch virus (TEV) protease cleavage site between an N-terminal 63His tag and the polylinker. All constructs were verified by DNA sequencing.
Expression and purification of full-length Get3 (wild type and D57N) was carried out as described previously 16 . Full-length Get1 and Get2 (wild type and mutants) were expressed in E. coli Rosetta2/pLysS (Novagen) using the Overnight Express Autoinduction System 1 (Novagen). Cells were disrupted in buffer A (50 mM HEPES, pH 8.0, 500 mM NaCl, 10 mM imidazole, 5% glycerol) with 1 mM PMSF using a high-pressure microfluidizer (Avestin), and the insoluble pellet was isolated by centrifugation. This pellet was washed in buffer A, recentrifuged and solubilized for 1 h at 4 uC in buffer A containing 0.5% n-dodecyl-N,N-dimethylamine-N-oxide (LDAO). The detergent-soluble fraction was then subjected to nickel-affinity chromatography (Ni-NTA agarose, Qiagen) in buffer A containing 30 mM imidazole and 0.1% LDAO. Protein was eluted at ,1 mg ml 21 in buffer A containing 200 mM imidazole and 0.1% LDAO, and stored in aliquots at 280 uC. Protein concentrations were determined using calculated A 280 extinction coefficients.
The cytosolic Get1 fragment (residues 21-104) was expressed for 3 h at 37 uC (wild type) or overnight at 25 uC (R73E mutant) in E. coli BL21(DE3)/pRIL (Novagen), following induction with 0.1 mM IPTG. Cells were disrupted in buffer B (50 mM Tris, pH 7.5, 500 mM NaCl, 10 mM imidazole, 5% glycerol, 5 mM b-mercaptoethanol) with 1 mM PMSF using a microfluidizer. After clearing by centrifugation, the supernatant was batch-purified by nickel-affinity chromatography. Protein was eluted in buffer B containing 200 mM imidazole, dialyzed into 10 mM Tris, pH 7.5, 250 mM NaCl and 40% glycerol, and then stored at 280 uC. This was typically followed by gel filtration (Superdex 200 10/300 GL, GE Healthcare) in 10 mM Tris, pH 7.5, and 200 mM NaCl. Fractions were pooled and stored in aliquots at 280 uC. Protein concentrations were determined using calculated A 280 extinction coefficients.
The cytosolic Get2 fragment (residues 1-38 or 1-106; wild type and R17E) was expressed with an N-or C-terminal 63His tag overnight at 25 uC and purified by nickel-affinity chromatography as described above for the Get1 fragment. After dialysis against 10 mM Tris, pH 7.5, and 200 mM NaCl, proteins were further purified by gel filtration in 10 mM Tris, pH 7.5, and 150 mM NaCl. Fractions were pooled, concentrated and stored in aliquots at 280 uC. Protein concentration was determined by BCA (Pierce). Preparation of liposomes. The standard liposome mixture typically contained PC:PE:rhodamine-PE at a mass ratio of 8:1.9:0.1. Rhodamine-PE serves as a tracer to follow the lipid recovery. Lipid solutions were mixed in the above ratios as chloroform stocks, adjusted to 10 mM DTT and dried in a glass tube by centrifugation under vacuum (SpeedVac, Eppendorf) for 12 h. Lipid films were hydrated to a final concentration of 20 mg ml 21 in lipid buffer (50 mM HEPES-KOH, pH 7.4, 15% glycerol) and mixed end to end for 6 h at 25 uC with intermittent vortexing. The milky and uniform suspension was subjected to three freeze-thaw cycles (freeze in liquid nitrogen; thaw at 37 uC) and extruded at 65 uC 11 times through 100-nm polycarbonate membranes using an Avanti mini-extruder 27, 29 . Single-use aliquots (100 ml) of the final clear liposome solution were flash-frozen in liquid nitrogen and stored at 280 uC. Purification of recombinant targeting complex. The DNA template for the double-Strep-tagged human Sec61b was generated by PCR using a 59 oligonucleotide that encodes the T7 promoter, start codon and tag. This template was transcribed and translated in RRL as described previously 28 , but with 0.15 mg ml 21 His-Get3 (added from a 20 mg ml 21 stock in 10 mM Tris-HCl, pH 7.5, 100 mM NaCl and 40% glycerol). A 2-ml translation reaction was diluted twofold with icecold column buffer (20 mM HEPES-KOH, pH 7.4, 100 mM potassium acetate, 2 mM magnesium acetate, 1 mM DTT) and centrifuged for 30 min at 540,960g in a TLA100.3 rotor at 4 uC. The post-ribosomal supernatant was bound to a 400-ml DEAE-Sepharose fast-flow column at 4 uC, washed with column buffer and eluted with a buffer containing 50 mM HEPES-KOH, pH 7.4, 320 mM potassium acetate, 7 mM magnesium acetate and 1 mM DTT. The elution was passed over 200 ml Strep-Tactin agarose (IBA, Germany) one to three times. After washing with four column volumes of Strep-Tactin buffer (50 mM HEPES-KOH, pH 7.4, 10% glycerol, 150 mM potassium acetate, 7 mM magnesium acetate, 1 mM DTT) at 4 uC, bound proteins were eluted with 5 3 50 ml Strep-Tactin buffer containing 10 mM Desthiobiotin (Novagen). The peak fractions, measured by counting radioactivity, were pooled. The final sample contained ,10,000 c.p.m. ml
21
. The concentration of Get3 in the final sample was estimated to be ,80 nM. Thus, the targeting complex in our typical preparation has a concentration of ,40 nM, assuming a 2:1 ratio of Get3 to Sec61b. This was either used immediately or frozen in aliquots in liquid nitrogen and stored at 280 uC. Targeting complexes containing the TMDs of rat VAMP2 and S. cerevisiae Sed5 in place of the Sec61b TMD were made similarly. Insertion assay. Post-translational insertion assay was performed as described before 8 , with the following minor modifications. For a standard reaction, 8 ml of purified targeting complex was mixed with 1 ml of ATP regenerating system (2 mM ATP, 10 mM creatine phosphate and 40 mg ml 21 creatine kinase) and 1 ml of yRMs, liposomes, reconstituted proteoliposomes or a matched buffer. ATP regenerating system was omitted in some reactions as indicated in the figure legends. After incubation at 32 uC for 30 min, the samples were treated with proteinase K (0.5 mg ml
) for 60 min on ice, and the protease digestion was terminated with 5 mM PMSF and transferred to 100 ml of boiling 1% SDS as described previously 8 . The protease-protected fragment was then immunoprecipitated using the 3F4 antibody directed against the C terminus of the Sec61b construct. Immunoprecipitated products were analysed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and quantified by phosphor imaging. Preparation of rough microsomes from yeast. Yeast microsomes were prepared by modifications of the methods previously described [30] [31] [32] 38 . TAP-tagged Get1 (Open Biosystems) or Get deletion strains (gift from T. Dever) were grown at 30 uC to a density of 2A 600 U in 1 l of YPD medium containing 2% glucose. Cells were collected by centrifugation at 3,000g for 5 min and washed twice with icecold distilled water. All subsequent steps were on ice or at 4 uC. The cell pellet was resuspended in 50 ml of homogenization buffer (20 mM HEPES-KOH, pH 7.4, 100 mM potassium acetate, 2 mM magnesium acetate) and centrifuged for 5 min at 3,000g. The resulting cell pellet was resuspended in homogenization buffer containing 2 mM DTT and protease inhibitor cocktail (Roche) at a concentration of 1 ml per gram of cell pellet. Pre-chilled glass beads were added (3 g ml 21 of suspension), and cell lysis was induced as follows: the tube was vigorously shaken up and down over a 50-cm path at ,1-2 cycles s 21 for three 1-min periods separated by 1 min chilling on ice. Approximately 50% of the cells were broken by this method as visualized by microscopy. The fluid phase was drained off through a fine nylon mesh into a JA17 tube and spun at 10,000g for 10 min. The post-mitochondrial supernatant was briefly centrifuged in a MLA80 rotor at 339,707g for 8 min. Each 2 ml of the clear supernatant was layered on 1 ml of 0.67 M sucrose cushion in homogenization buffer and centrifuged for 30 min in a TLA100.3 rotor at 265,070g. The resulting membrane pellet was resuspended in homogenization buffer containing 250 mM sucrose and 2 mM DTT to a final standard concentration of 100A 280 (measured after solubilization in 1% SDS). At this concentration, 1 ml yRM is defined as two equivalents (equiv.). One litre of culture yielded about 2,400 equiv. Aliquots were frozen in liquid nitrogen and stored at 280 uC. Depletion of Get1 and Get2 from microsomal extract. TAP-Get1 yRMs (1.5 ml, or 1,500 equiv.) were adjusted to 1% DBC in solubilization buffer (50 mM HEPES-KOH, pH 7.4, 500 mM potassium acetate, 5 mM magnesium acetate, 250 mM sucrose, 1 mM DTT and protease inhibitor cocktail). After 10 min incubation on ice, the detergent extract was centrifuged at 540,960g for 30 min in a TLA100.3 rotor at 4 uC. The supernatant (yRM extract) was incubated with 0.1 ml of IgG Sepharose (GE Healthcare) for 1 h at 25 uC. The unbound fraction was incubated with 0.1 ml of anti-Get2 antibodies coupled to protein-A agarose for 1 h at 25 uC. The flow-through was finally incubated with a mixture of 0.1 ml each of anti-Get1 and anti-Get2-antibodies coupled to protein-A agarose for 1 h at 25 uC. The flow-through from this column was used for reconstitution studies. It should be noted that a residual amount of the Get1/2 complex is sufficient to achieve the maximal insertion under in vitro conditions. Therefore, multiple rounds of depletion of the Get1/2 complex (with at least ,95% depletion) were necessary to fully deplete insertion activity. For purification of TAP-Get1 (and ARTICLE RESEARCH associated proteins), the IgG Sepharose resin from above was washed with lowsalt buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 10% glycerol, 0.25% DBC and 1 mM DTT) and eluted with 70 U TEV-protease (Invitrogen) overnight at 4 uC. The TEV elution was adjusted to 2.5 mM CaCl 2 , and incubated with calmodulin Sepharose (GE Healthcare) for 90 min at 4 uC. The beads were washed with low-salt buffer containing CaCl 2 and eluted with low-salt buffer containing 5 mM EGTA. The eluted proteins were precipitated with TCA and analysed by SDS-PAGE. Reconstitution of proteoliposomes from microsome extracts. Following earlier methods 30, 33, 34 , yRMs were adjusted to a concentration of 1 equiv. ml 21 in the following conditions: 50 mM HEPES-KOH, pH 7.4, 500 mM potassium acetate, 5 mM magnesium acetate, 250 mM sucrose, 1 mM DTT, 1% DBC and protease inhibitor cocktail. After 10 min on ice, the ribosomes were removed by centrifugation at 540,960g. for 30 min in a TLA100.3 rotor at 4 uC. Typically, 100 ml of this clarified yRM extract was mixed with 10 ml of liposomes (200 mg) and 50 mg of Biobeads SM2 (Bio-Rad). The Biobeads were prewashed extensively ahead of time with methanol and water. The mixture was incubated for 12-16 h with gentle overhead mixing at 4 uC. The fluid phase was separated from the beads, diluted with five volumes of ice-cold distilled water and sedimented in a TLA100.3 rotor in micro-test tubes at 304,290g for 30 min at 4 uC. The proteoliposomes were resuspended in 25 ml of membrane buffer (50 mM HEPES-KOH, pH 7.4, 100 mM potassium acetate, 5 mM magnesium acetate, 250 mM sucrose, and 1 mM DTT). Reconstitution of proteoliposomes with purified proteins. The optimum method for reconstitution of purified Get1 or Get2 was empirically determined after testing various detergents and reconstitution methods ( Supplementary Fig. 17 ) The precise method of reconstitution proved to be important for obtaining maximally functional proteoliposomes. The incorporation and activity of Get1 and Get2 varied with different detergents. Of those tested, DBC worked the best to achieve the maximal activity of Get1 and Get2. Every batch of DBC requires some degree of optimization with respect to the amount of Biobeads used for detergent removal. For a standard reconstitution reaction, 100 ml of reconstitution buffer (50 mM HEPES-KOH, pH 7.4, 500 mM potassium acetate, 5 mM magnesium acetate, 250 mM sucrose, 1 mM DTT, 0.25% DBC) was mixed with 10 ml of liposome (200 mg) and purified Get1 or Get2 at the desired concentration. For preparation of liposomes used as controls in the assays, purified proteins were omitted. This mixture was added to between 25 and 30 mg of Biobeads (optimized for each batch of DBC), and incubated with overhead mixing for 12 h at 4 uC. The fluid phase was separated and diluted with five volumes of ice-cold water. In some instances, the proteoliposomes were mixed with Get3 and incubated for 15 min at 25 uC, followed by 30 min at 4 uC with shaking, to allow binding. After dilution, the liposomes were sedimented in a TLA100.3 rotor in micro-test tubes at 304,290g for 30 min at 4 uC. The proteoliposomes were resuspended in 25 ml of membrane buffer as above. SDS-PAGE Coomassie staining and immunoblots were performed to assess the efficiency of protein incorporation; the rhodamine-PE served as a marker for lipid recovery. Typical recovery for Get1 and Get2 reconstitution was ,50%. Multi-angle light scattering. The absolute molecular masses of individual proteins and complexes were measured by static multi-angle light scattering. Purified samples were injected onto a Superdex 200 HR 10/30 gel filtration column (GE Healthcare) equilibrated with 10 mM Tris, pH 7.5, 150 mM NaCl and 2 mM DTT. The purification system was coupled to an online, static, lightscattering detector (Dawn HELEOS II, Wyatt Technology), a refractive-index detector (Optilab rEX, Wyatt Technology) and a ultraviolet-light detector
